Department of Urology, Ohio State University, Columbus, OH, USA.
Department of Urology, Zuckerberg San Francisco General Hospital and Trauma Center, University of California San Francisco, 1001 Potrero Suite 3A, San Francisco, CA, 94110, USA.
World J Urol. 2019 Dec;37(12):2763-2768. doi: 10.1007/s00345-019-02653-6. Epub 2019 Feb 2.
To assess the functional Queryoutcome of patients with cystoscopic recurrence of stricture post-urethroplasty and to evaluate the role of cystoscopy as initial screening tool to predict future failure.
Cases with cystoscopy data after anterior urethroplasty in a multi-institutional database were retrospectively studied. Based on cystoscopic evaluation, performed within 3-months post-urethroplasty, patients were categorized as small-caliber (SC) stricture recurrence: stricture unable to be passed by standard cystoscope, large-caliber (LC) stricture accommodating a cystoscope, and no recurrence. We assessed the cumulative probability of intervention and the quality of life scores in association with cystoscopic recurrence 1-year post-urethroplasty. Patients with history of hypospadias, perineal urethrostomy, urethral fistula, and meatal pathology were excluded.
From a total of 2630 men in our cohort, 1054 patients met the inclusion criteria: normal (n = 740), LC recurrence (n = 178), and SC recurrence (n = 136) based on the first cystoscopic evaluation performed at median 111 days postoperatively. Median follow-up was 350 days (IQR 121-617) after urethroplasty. Cystoscopic recurrence was significantly associated with secondary interventions (2.7%, 6.2%, 33.8% in normal, LC, and SC groups, respectively). Quality of life variables were not statistically significantly different among the three study groups.
Many patients with cystoscopic recurrence do not need an intervention after initial urethroplasty. Despite good negative predictive value, cystoscopy alone may be a poor screening test for stricture recurrence defined by patient symptoms and need for secondary interventions.
评估经尿道扩张术后因狭窄而再次出现膀胱镜复发的患者的功能结局,并评估膀胱镜检查作为预测未来失败的初始筛查工具的作用。
对多机构数据库中接受经尿道前尿道成形术后有膀胱镜数据的病例进行回顾性研究。根据术后 3 个月内进行的膀胱镜评估,将患者分为小口径(SC)狭窄复发:狭窄无法通过标准膀胱镜通过、大口径(LC)狭窄可容纳膀胱镜和无复发。我们评估了 1 年后与膀胱镜复发相关的干预累积概率和生活质量评分。排除有尿道下裂、会阴尿道造口术、尿道瘘和尿道口病变病史的患者。
在我们的队列中,共有 2630 名男性,其中 1054 名患者符合纳入标准:正常(n=740)、LC 复发(n=178)和 SC 复发(n=136),这是基于术后中位数 111 天进行的首次膀胱镜检查评估。尿道成形术后中位随访时间为 350 天(IQR 121-617)。膀胱镜复发与二次干预显著相关(正常、LC 和 SC 组分别为 2.7%、6.2%和 33.8%)。三个研究组之间的生活质量变量没有统计学差异。
许多膀胱镜检查复发的患者在初次尿道成形术后不需要进行干预。尽管具有良好的阴性预测值,但单独的膀胱镜检查可能是一种对以患者症状和二次干预需要为定义的狭窄复发的筛查试验较差。